Acadia Pharmaceuticals is dedicated to transforming scientific discoveries into significant innovations for underserved neurological and rare disease communities globally. The company's commercial portfolio includes FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome, and it is actively developing new therapeutic advancements with a robust pipeline, including mid- to late-stage programs for Alzheimer’s disease psychosis and Lewy body dementia psychosis, as well as earlier-stage programs addressing other patient needs. This position can be based in Princeton, NJ, or San Diego, CA, and operates under Acadia's hybrid model, requiring an average of 3 days per week in the office. The role is responsible for the chemical process development, implementation, and management of robust, cost-effective, and safe processes for manufacturing Active Pharmaceutical Ingredients (APIs) from the research stage through clinical development and marketing approval. This includes technical development, support, innovative solutions, and commercialization of drug substances through an external network of providers. The position is crucial for advancing ACADIA’s growing portfolio of drug candidates, providing technical oversight, expertise, and guidance for externalized drug substance development activities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees